|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 47, 622-632, March 2006 Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B
* Cardiovascular Genetics Laboratory, Department of Medicine, Division of Cardiology, McGill University Health Centre/Royal Victoria Hospital, Montréal, Québec, Canada Published, JLR Papers in Press, November 30, 2005.
1 To whom correspondence should be addressed. e-mail: michel.marcil{at}mcgill.ca
We previously reported that human Niemann-Pick Disease type B (NPD-B) is associated with low HDL. In this study, we investigated the pathophysiology of this HDL deficiency by examining both HDL samples from NPD-B patients and nascent high density lipoprotein (LpA-I) generated by incubation of lipid-free apolipoprotein A-I (apoA-I) with NPD-B fibroblasts. Interestingly, both LpA-I and HDL isolated from patient plasma had a significant increase in sphingomyelin (SM) mass (
Supplementary key words high density lipoprotein nascent LpA-I phospholipids sphingomyelin phosphodiesterase-1 gene sphingomyelinase Abbreviations: apoA-I, apolipoprotein A-I; CE, cholesteryl ester; ESI-MS, electrospray ionization-mass spectrometry; FC, free cholesterol; HDL-C, high density lipoprotein-cholesterol; LpA-I, nascent apoA-I-containing particle; NPD-A/B, Niemann-Pick disease type A and B; PC, phosphatidylcholine; PL, phospholipid; rLpA-I, reconstituted apolipoprotein A-I-containing proteoliposomes; SM, sphingomyelin; SMase, sphingomyelinase; SMPD-1, sphingomyelin phosphodiesterase-1 gene; S-SMase, secretory sphingomyelinase; SR-BI, scavenger receptor class B type I; TD, Tangier disease; 2D-PAGGE, two-dimensional polyacrylamide nondenaturing gradient gel electrophoresis; 22OH/9CRA, 2.5 µg/ml 22(R)-hydroxycholesterol and 5 µM 9-cis-retinoic acid
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||